64-Week Weight Loss Study for Adults With Overweight or Obesity and Type 2 Diabetes
Are you living with type 2 diabetes and looking to lose weight?
You may be eligible to participate in a clinical research study evaluating an investigational medication called petrelintide for weight management.
ABOUT THE STUDY
This is a Phase 3 clinical research study which is assessing how once-weekly petrelintide affects body weight in adults living with overweight or obesity and type 2 diabetes.
WHO MAY QUALIFY?
You may be eligible to participate if you meet all the following:
Are 18 years of age or older
Body mass index (BMI) of 27 or higher (classified as overweight or obesity)
Have type 2 diabetes
Have an HbA1c between 6.5% and 10.0%
Have not had any changes in your diabetes medications during the past 3 months
Have not used any GLP-1-based medication — including pills or injections (such as Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, or Foundayo) within the past 6 months
Have never had surgery for treatment of obesity
INTERESTED IN LEARNING MORE?
Click below to complete a short questionnaire to see if you may be eligible.